Biotechnology stocks and the related exchange traded funds are in a prolonged slump, and along the way, calls for rebounds have been plentiful. They’ve also proven inaccurate. No, biotech stocks and ETFs such as the VanEck Vectors Biotech ETF (BBH) won’t be out of favor permanently. Pinpointing...